DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has filed a disclosure under SEBI's insider trading regulations, which is a routine compliance requirement. This type of filing is made when a promoter, director, or key managerial person trades in the company's shares. The specific details of the trade — such as who traded, the number of shares, and the price — are not available in the source document, as the BSE page returned an error. Without the actual data, the nature and scale of the insider transaction cannot be confirmed.
Reg 7(2) disclosures themselves are routine compliance filings and typically have no direct impact on stock price. Once the actual trade details are available, investors should check whether the insider bought or sold shares, as purchases by promoters often signal confidence while sales may warrant closer scrutiny.